Liverpool University Hospitals NHS Foundation Trust
š¬š§United Kingdom
- Country
- š¬š§United Kingdom
- Ownership
- Private
- Established
- 2019-10-01
- Employees
- 10K
- Market Cap
- -
- Website
- https://www.rlbuht.nhs.uk
Clinical Trials
75
Active:8
Completed:37
Trial Phases
5 Phases
Phase 1:7
Phase 2:2
Phase 3:4
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (41 trials with phase data)ā¢ Click on a phase to view related trials
Not Applicable
25 (61.0%)Phase 1
7 (17.1%)Phase 3
4 (9.8%)Phase 4
3 (7.3%)Phase 2
2 (4.9%)Air Tamponade Versus Fluorinated Gas Tamponade for Rhegmatogenous Retinal Detachment
Not Applicable
Not yet recruiting
- Conditions
- Retinal Detachment Rhegmatogenous
- First Posted Date
- 2025-06-24
- Last Posted Date
- 2025-06-24
- Target Recruit Count
- 150
- Registration Number
- NCT07034469
Intelligent Monitoring to Predict Atrial Fibrillation
Suspended
- Conditions
- Atrial Fibrillation New OnsetAtrial FibrillationPostoperative Cardiovascular Complications
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2025-09-15
- Target Recruit Count
- 1200
- Registration Number
- NCT06600620
- Locations
- š¬š§
Liverpool university foundation trust, Liverpool, United Kingdom
š¬š§Liverpool University hospital Foundation trust, Liverpool, United Kingdom
Safety, Tolerability and Performance of the NucleoCapture Extracorporeal Therapeutic Apheresis Device in the Reduction of Circulating cfDNA/NETs in Subjects With Pancreatitis
Not Applicable
Not yet recruiting
- Conditions
- Acute PancreatitisOrgan Failure, Multiple
- First Posted Date
- 2024-08-22
- Last Posted Date
- 2025-03-20
- Target Recruit Count
- 20
- Registration Number
- NCT06566638
- Locations
- š¬š§
Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom
EffiCacy and sAfEty of Low doSe orAl iRon for Anaemia in IBD
Phase 3
Recruiting
- Conditions
- Iron Deficiency AnemiaInflammatory Bowel Disease
- Interventions
- Drug: Ferrous fumarate syrup 2.5ml/70mg (22.5mg elemental iron)Drug: Ferrous fumarate syrup 2.5ml/70mg(45mg elemental iron)Drug: Ferrous fumarate syrup 2.5ml/70mg (90mg elemental iron)
- First Posted Date
- 2024-03-20
- Last Posted Date
- 2024-03-20
- Target Recruit Count
- 30
- Registration Number
- NCT06321887
- Locations
- š¬š§
Liverpool University Foundation NHS Trust, Liverpool, United Kingdom
ADAPT-AST (Adaptive Antimicrobial Susceptibility Testing)
Active, not recruiting
- Conditions
- Urinary Tract Infections
- First Posted Date
- 2024-03-07
- Last Posted Date
- 2025-02-04
- Target Recruit Count
- 500000
- Registration Number
- NCT06297837
- Locations
- š¬š§
Liverpool University Hospitals NHS Foundation Trust, Liverpool, North West, United Kingdom
- Prev
- 1
- 2
- 3
- 4
- 5
- 14
- Next
News
No news found